Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24197712)

cardiovascular disease in women

inferred from title

0 references

author

Xavier Bonfill Cosp

7

0 references

Marta Roqué

6

0 references

author name string

Caroline Main

1

0 references

Beatrice Knight

2

0 references

Tiffany Moxham

3

0 references

Rafael Gabriel Sanchez

4

0 references

Luis Maria Sanchez Gomez

Cochrane Database of Systematic Reviews

5

0 references

publication date

30 April 2013

0 references

published in

0 references

cites work

Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Women's angiographic vitamin and estrogen trial: design and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Implementation of the women's health initiative study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

The Women's Health Initiative recruitment methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Women's health initiative studies of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone replacement therapy (HRT)--risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen replacement therapy, atherosclerosis, and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Hormone replacement therapy and stroke: risk, protection or no effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

A case-control study of myocardial infarction in relation to use of estrogen supplements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Prolonged estrogen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Age at Natural Menopause and Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

Increased incidence of coronary heart disease in women castrated prior to the menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Estrogen replacement therapy: an overview.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Does age at natural menopause affect mortality from ischemic heart disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Development of a brief screening instrument for detecting depressive disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Silent ischemia during daily life is an independent predictor of mortality in stable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

A practical guide to prescribing hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB3

7 January 2021